XML 35 R21.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

REVENUES (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
REVENUES |
Schedule of Company's disaggregation of revenues | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Six Months Ended June 30, | ​ |  | ​ | Three Months Ended June 30, | ​
(U.S. dollars in thousands) |  | 2024 |  | 2023 | ​ | ​ | ​ | 2024 |  | 2023 | ​
Pfizer | ​ | $ | 8,001 | ​ | $ | 5,668 | ​ | ​ | ​ | $ | 6,874 | ​ | $ | 3,402 | ​
Brazil | ​ | $ | 7,266 | ​ | $ | 2,800 | ​ | ​ | ​ | $ | 4,716 | ​ | $ | — | ​
Chiesi | ​ | $ | 1,714 | ​ | $ | 11,673 | ​ | ​ | ​ | $ | 1,714 | ​ | $ | 11,673 | ​
Total revenues from selling goods | ​ | $ | 16,981 | ​ | $ | 20,141 | ​ | ​ | ​ | $ | 13,304 | ​ | $ | 15,075 | ​
Revenues from license and R&D services | ​ | $ | 241 | ​ | $ | 24,522 | ​ | ​ | ​ | $ | 170 | ​ | $ | 20,000 | ​
​

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration